Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis

被引：19
作者：
Younus, J. [1 ]
Vandenberg, T. [1 ]
Jawaid, M. [2 ]
Jawaid, M. A. [3 ]
机构：
[1] London Reg Canc Program, Dept Med Oncol, London, ON N6A 4L6, Canada
[2] Univ Western Ontario, Schulich Sch Med, London, ON, Canada
[3] Univ Western Ontario, Dept Social Sci, London, ON, Canada
来源：
CURRENT ONCOLOGY | 2012年 / 19卷 / 06期
关键词：
Febrile neutropenia; breast cancer; adjuvant chemotherapy; RANDOMIZED-TRIALS; METAANALYSIS; DOXORUBICIN; OUTCOMES; OLDER;
D O I：
10.3747/co.19.1174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：332 / 334
页数：3
相关论文
共 47 条
[21]   Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer [J].
Joris, Sofie ;
Fontaine, Christel ;
Decoster, Lore ;
Vanacker, Leen ;
Schallier, Denis ;
De Greve, Jacques .
BREAST JOURNAL, 2019, 25 (04) :663-666
[22]   Early neutropenia on day 8 treated with adjuvant Docetaxel-based chemotherapy in early breast cancer patients: Putative mechanisms within the neutrophil pool system [J].
Furuya, Yoshihiko .
PLOS ONE, 2019, 14 (04)
[23]   Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy [J].
Yoshimasa Kosaka ;
Yoshiaki Rai ;
Norikazu Masuda ;
Toshimi Takano ;
Toshiaki Saeki ;
Seigo Nakamura ;
Ryutaro Shimazaki ;
Yoshinori Ito ;
Yutaka Tokuda ;
Kazuo Tamura .
Supportive Care in Cancer, 2015, 23 :1137-1143
[24]   Time trends in utilization of G-CSF prophylaxis and risk of febrile neutropenia in a Medicare population receiving adjuvant chemotherapy for early-stage breast cancer [J].
Ravi K. Goyal ;
Spiros Tzivelekis ;
Kenneth J. Rothman ;
Sean D. Candrilli ;
James A. Kaye .
Supportive Care in Cancer, 2018, 26 :539-548
[25]   Time trends in utilization of G-CSF prophylaxis and risk of febrile neutropenia in a Medicare population receiving adjuvant chemotherapy for early-stage breast cancer [J].
Goyal, Ravi K. ;
Tzivelekis, Spiros ;
Rothman, Kenneth J. ;
Candrilli, Sean D. ;
Kaye, James A. .
SUPPORTIVE CARE IN CANCER, 2018, 26 (02) :539-548
[26]   Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC) [J].
Clemons, Mark ;
Mazzarello, Sasha ;
Hilton, John ;
Joy, Anil ;
Price-Hiller, Julie ;
Zhu, Xiaofu ;
Verma, Shailendra ;
Kehoe, Anne ;
Ibrahim, Mohammed F. K. ;
Sienkiewicz, Marta ;
Stober, Carol ;
Vandermeer, Lisa ;
Hutton, Brian ;
Mallick, Ranjeeta ;
Fergusson, Dean .
SUPPORTIVE CARE IN CANCER, 2019, 27 (04) :1345-1354
[27]   Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials [J].
Caparica, Rafael ;
Bruzzone, Marco ;
Poggio, Francesca ;
Ceppi, Marcello ;
de Azambuja, Evandro ;
Lambertini, Matteo .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (01) :27-37
[28]   Treatment patterns for adjuvant docetaxel-based chemotherapy in early-stage breast cancer in China: A pooled retrospective analysis of four observational studies [J].
Xu, Binghe ;
Shao, Zhimin ;
Wang, Shui ;
Jiang, Zefei ;
Hu, Xichun ;
Zhang, Xiaohua ;
Li, Xiru ;
Liu, Jinping ;
Li, Mengquan ;
Wang, Shu .
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (03) :327-+
[29]   Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study [J].
Tomomatsu, Takuya ;
Shimizu, Hisanori ;
Yokokawa, Takashi ;
Fukada, Ippei ;
Kawakami, Kazuyoshi ;
Kobayashi, Kazuo ;
Aoyama, Takeshi ;
Suzuki, Wataru ;
Sugisaki, Takahito ;
Hashimoto, Koki ;
Asano, Maimi ;
Mori, Yuka ;
Hara, Fumikata ;
Takano, Toshimi ;
Ohno, Shinji ;
Yamaguchi, Masakazu .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2024, 144 (09) :897-904
[30]   Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC) [J].
Mark Clemons ;
Sasha Mazzarello ;
John Hilton ;
Anil Joy ;
Julie Price-Hiller ;
Xiaofu Zhu ;
Shailendra Verma ;
Anne Kehoe ;
Mohammed FK Ibrahim ;
Marta Sienkiewicz ;
Carol Stober ;
Lisa Vandermeer ;
Brian Hutton ;
Ranjeeta Mallick ;
Dean Fergusson .
Supportive Care in Cancer, 2019, 27 :1345-1354
12345